Sageworth Trust’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,508
| Closed | -$112K | – | 173 |
|
|
2023
Q1 | $112K | Buy |
1,508
+1,212
| +409% | +$90.1K | 0.01% | 106 |
|
|
2022
Q4 | $27K | Buy |
296
+13
| +5% | +$1.19K | ﹤0.01% | 155 |
|
|
2022
Q3 | $27K | Hold |
283
| – | – | ﹤0.01% | 140 |
|
|
2022
Q2 | $26K | Hold |
283
| – | – | ﹤0.01% | 182 |
|
|
2022
Q1 | $29K | Hold |
283
| – | – | ﹤0.01% | 119 |
|
|
2021
Q4 | $30K | Sell |
283
-152
| -35% | -$16.1K | ﹤0.01% | 141 |
|
|
2021
Q3 | $37K | Sell |
435
-4,548
| -91% | -$387K | ﹤0.01% | 238 |
|
|
2021
Q2 | $416K | Buy |
4,983
+4,548
| +1,046% | +$380K | 0.03% | 77 |
|
|
2021
Q1 | $33K | Sell |
435
-537
| -55% | -$40.7K | ﹤0.01% | 202 |
|
|
2020
Q4 | $66K | Buy |
972
+722
| +289% | +$49K | 0.01% | 106 |
|
|
2020
Q3 | $15K | Buy |
250
+230
| +1,150% | +$13.8K | ﹤0.01% | 129 |
|
|
2020
Q2 | $1K | Buy |
20
+5
| +33% | +$250 | ﹤0.01% | 179 |
|
|
2020
Q1 | $1K | Hold |
15
| – | – | ﹤0.01% | 163 |
|
|
2019
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 186 |
|
|
2019
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 166 |
|
|
2019
Q2 | $1K | Sell |
15
-600
| -98% | -$40K | ﹤0.01% | 173 |
|
|
2019
Q1 | $33K | Sell |
615
-1,621
| -72% | -$87K | ﹤0.01% | 109 |
|
|
2018
Q4 | $147K | Buy |
2,236
+21
| +0.9% | +$1.38K | 0.02% | 47 |
|
|
2018
Q3 | $174K | Buy |
2,215
+1,600
| +260% | +$126K | 0.02% | 43 |
|
|
2018
Q2 | $40K | Buy |
615
+600
| +4,000% | +$39K | 0.01% | 52 |
|
|
2018
Q1 | $1K | Hold |
15
| – | – | ﹤0.01% | 124 |
|
|
2017
Q4 | $1K | Hold |
15
| – | – | ﹤0.01% | 97 |
|
|
2017
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 64 |
|
|
2017
Q2 | $1K | Sell |
15
-150
| -91% | -$10K | ﹤0.01% | 112 |
|
|
2017
Q1 | $13K | Buy |
165
+150
| +1,000% | +$11.8K | ﹤0.01% | 68 |
|
|
2016
Q4 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 53 |
|
|
2015
Q1 | – | Sell |
-2,687
| Closed | -$259K | – | 47 |
|
|
2014
Q4 | $259K | Buy |
+2,687
| New | +$259K | 0.08% | 82 |
|